Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease - Wikidata - awgldk - TriplyDB

Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease

Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease

http://www.wikidata.org/entity/Q33870409

about

Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease Challenges and perspectives of Chagas disease: a review.Metallothionein-1 and nitric oxide expression are inversely correlated in a murine model of Chagas disease.New drugs for neglected infectious diseases: Chagas' disease.In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease.Nitro/nitrosyl-ruthenium complexes are potent and selective anti-Trypanosoma cruzi agents causing autophagy and necrotic parasite death The use of a heterogeneously controlled mouse population reveals a significant correlation of acute phase parasitemia with mortality in Chagas disease.Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones.Nitric oxide and Brazilian propolis combined accelerates tissue repair by modulating cell migration, cytokine production and collagen deposition in experimental leishmaniasis.Advances in Chagas disease drug development: 2009-2010 Developments in the management of Chagas cardiomyopathy.Current status of Chagas disease chemotherapy.Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence.Therapeutical approaches under investigation for treatment of Chagas disease.Antileishmanial Activity and Inducible Nitric Oxide Synthase Activation by RuNO Complex Experimental chemotherapy in paracoccidioidomycosis using ruthenium NO donor.Reactivity, photolability, and computational studies of the ruthenium nitrosyl complex with a substituted cyclam fac-[Ru(NO)Cl2(κ3N4,N8,N11(1-carboxypropyl)cyclam)]Cl·H2O.Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis.

P2860

Q28543494-81526E14-3864-4416-922A-736E8C5299A5 Q30566256-6A857106-3040-43FA-AFD8-BCEB74408559 Q33587079-039E6618-B25A-4BAE-99BE-E7A2223C8985 Q33870393-303B68A9-8A82-40AB-8630-7EB3F457F806 Q34045200-2226780C-A94F-438D-8FFE-500A29B5E61E Q34299137-F15ED68B-20B8-45DF-9135-275A880FFACA Q35126647-882F6044-4EED-4919-802B-8363BFD758F0 Q35367533-9C7B2C6F-9B21-4DB2-8B5F-5396BB1A79BB Q35606881-F84534FE-362B-4B87-873C-D27E61BC47C5 Q36702159-386549D8-75A8-490F-8DA9-EF9344D75CE4 Q36737035-48CB4BD8-4E09-4792-8C91-CB92E5832AB7 Q37879205-41A12DB2-8E74-464A-93BA-F393E9F196D6 Q38017721-D946DACB-3003-409E-8BD5-8FF49DFC37C4 Q38214136-BAE53686-9F94-45BB-9F51-7332A124F3CF Q39214557-7C1A1297-7FC9-4518-B287-9DC495897EC5 Q44684976-9212FD58-D69E-4EDB-A39B-8ECCAEB6006F Q45770256-53912B85-3634-413A-BE8E-BF0BEF11EA38 Q52718692-A3C6D8F5-64AD-4367-A4EF-F6C50043DAB7

P2860

Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease

http://www.wikidata.org/entity/Q33870409

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Nitric oxide donor trans-[RuCl ...... c approach for Chagas' disease

@ast

Nitric oxide donor trans-[RuCl ...... c approach for Chagas' disease

@en

type

label

Nitric oxide donor trans-[RuCl ...... c approach for Chagas' disease

@ast

Nitric oxide donor trans-[RuCl ...... c approach for Chagas' disease

@en

prefLabel

Nitric oxide donor trans-[RuCl ...... c approach for Chagas' disease

@ast

Nitric oxide donor trans-[RuCl ...... c approach for Chagas' disease

@en

P1433

Q33870409-633A3ABA-45AF-4FE5-BAF2-5F87EEC2F3A8

P1476

Q33870409-FC2F5792-A16B-46AC-B36A-7283D5C0BF1A

P2093

Q33870409-1733E211-0037-4949-8A9B-7D7F86059C5F

Q33870409-39207F8A-4A47-4088-9F49-4E0EB5062B35

Q33870409-44CA466B-05B8-4AEB-9D0E-3FF743532D20

Q33870409-629728F8-2BB2-4FAE-AFBB-95037C29EC05

Q33870409-8C072DD6-E7C9-4A63-BCE3-6F58051F936E

Q33870409-9CA2E427-4947-4234-894C-C7CFE74C5B8E

Q33870409-A4066143-5B11-401A-B1CC-AD0A40EECFEB

Q33870409-D986291E-8BD2-4CB3-9607-5C57871207D9

Q33870409-EEB77267-0BBD-4E85-8A93-C11910EF08C4

Q33870409-F738FB4A-475A-4A7E-B9A2-56D261907B9B

P2860

Q33870409-082DD2C0-C63B-452E-8839-9CD2B20A38E4

Q33870409-0D6D82C1-687F-4F0A-8585-B431D5153460

Q33870409-1350DA4B-544E-41F1-B849-C00305B2A75B

Q33870409-18498EB8-628F-4CD9-9115-CACE89AC6CE6

Q33870409-1C8F7A41-58C4-4D05-803A-38791F782C0D

Q33870409-1CCB03AC-B279-4F81-A930-042839D19857

Q33870409-21FA452A-B1DE-42F2-AFE4-7D7F08524675

Q33870409-234FD02D-168F-4D20-90CE-93F5F0A380EA

Q33870409-34C5E131-A852-4008-A5A2-910DFBED6FAE

Q33870409-384E7C86-5CB6-45EA-B4F0-94347BF9E44F

P304

Q33870409-4A95BA2A-B481-48AB-9A71-E1E6A9B13C09

P31

Q33870409-E0D434DF-7799-48D2-910B-E20719470835

P356

Q33870409-7244D96B-3F0C-47F4-9588-609C1CF3AEB0

P407

Q33870409-E98391D3-0C2F-44FA-BC7A-A2A6D82A036E

P433

Q33870409-92995E60-18E6-401B-B193-D089ECBBD310

P478

Q33870409-3121FEB0-66EB-4DD5-8BED-12A8591A7DE6

P577

Q33870409-CC8402BF-FDEE-4C11-A061-68F7FD3FC3FF

P5875

Q33870409-4D6CC862-2962-4962-B745-184076A91546

P698

Q33870409-D32C725E-6F19-4C6B-8BDA-164799135693

P921

Q33870409-D9EF7F9B-593E-4335-939B-D933E8411447

P932

Q33870409-F1D894BE-5521-4630-8E84-BE6DFF8B7E1B

P356

J.1476-5381.2009.00576.X

P1433

British Journal of Pharmacology

P1476

Nitric oxide donor trans-[RuCl ...... c approach for Chagas' disease

@en

P2093

Dario S Zamboni

http://www.w3.org/2001/XMLSchema#string

Douglas W Franco

http://www.w3.org/2001/XMLSchema#string

Fabiana S Oliveira

http://www.w3.org/2001/XMLSchema#string

Fredy R S Gutierrez

http://www.w3.org/2001/XMLSchema#string

Gerson Jhonatan Rodrigues

http://www.w3.org/2001/XMLSchema#string

Grace Kelly da Silva

http://www.w3.org/2001/XMLSchema#string

João Santana Silva

http://www.w3.org/2001/XMLSchema#string

Lusiane Maria Bendhack

http://www.w3.org/2001/XMLSchema#string

Maria A Do Valle Matta

http://www.w3.org/2001/XMLSchema#string

Paulo M M Guedes

http://www.w3.org/2001/XMLSchema#string

P2860

Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens

Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina

Nitric oxide and the immune response

Parasitological cure of Chagas disease: is it possible? Is it relevant?

Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina.

Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity.

The role of nitric oxide in innate immunity.

Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives.

Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts

beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi

P304

270-282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2009.00576.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41403790

http://www.w3.org/2001/XMLSchema#string

P698

20128813

http://www.w3.org/2001/XMLSchema#string

P921

P932

2874850

http://www.w3.org/2001/XMLSchema#string